These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 988636)
21. The dopamine theory of attention deficit hyperactivity disorder (ADHD). Levy F Aust N Z J Psychiatry; 1991 Jun; 25(2):277-83. PubMed ID: 1652243 [TBL] [Abstract][Full Text] [Related]
22. Visual-motor performance in minimal brain dysfunction and normal children. Cakirpaloglu P; Radil T Act Nerv Super (Praha); 1990 Mar; 32(1):79-80. PubMed ID: 2363350 [No Abstract] [Full Text] [Related]
23. In vivo occupancy of dopamine D3 receptors by antagonists produces neurochemical and behavioral effects of potential relevance to attention-deficit-hyperactivity disorder. Barth V; Need AB; Tzavara ET; Giros B; Overshiner C; Gleason SD; Wade M; Johansson AM; Perry K; Nomikos GG; Witkin JM J Pharmacol Exp Ther; 2013 Feb; 344(2):501-10. PubMed ID: 23197772 [TBL] [Abstract][Full Text] [Related]
24. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity. Jucaite A; Fernell E; Halldin C; Forssberg H; Farde L Biol Psychiatry; 2005 Feb; 57(3):229-38. PubMed ID: 15691523 [TBL] [Abstract][Full Text] [Related]
25. Testing computational models of dopamine and noradrenaline dysfunction in attention deficit/hyperactivity disorder. Frank MJ; Santamaria A; O'Reilly RC; Willcutt E Neuropsychopharmacology; 2007 Jul; 32(7):1583-99. PubMed ID: 17164816 [TBL] [Abstract][Full Text] [Related]
26. Swimming exercise alleviates the symptoms of attention-deficit hyperactivity disorder in spontaneous hypertensive rats. Ko IG; Kim SE; Kim TW; Ji ES; Shin MS; Kim CJ; Hong MH; Bahn GH Mol Med Rep; 2013 Aug; 8(2):393-400. PubMed ID: 23779147 [TBL] [Abstract][Full Text] [Related]
27. Differential behavioral and neurochemical effects of cocaine after early exposure to methylphenidate in an animal model of attention deficit hyperactivity disorder. Augustyniak PN; Kourrich S; Rezazadeh SM; Stewart J; Arvanitogiannis A Behav Brain Res; 2006 Feb; 167(2):379-82. PubMed ID: 16246436 [TBL] [Abstract][Full Text] [Related]
29. Neuropharmacological basis of stimulant drug action in attention deficit disorder with hyperactivity: a review and synthesis. Solanto MV Psychol Bull; 1984 May; 95(3):387-409. PubMed ID: 6152684 [No Abstract] [Full Text] [Related]
30. Motor hyperactivity caused by a deficit in dopaminergic neurons and the effects of endocrine disruptors: a study inspired by the physiological roles of PACAP in the brain. Masuo Y; Morita M; Oka S; Ishido M Regul Pept; 2004 Dec; 123(1-3):225-34. PubMed ID: 15518916 [TBL] [Abstract][Full Text] [Related]
31. Reduced extracellular dopamine and increased responsiveness to novelty: neurochemical and behavioral sequelae of intermittent hypoxia. Decker MJ; Jones KA; Solomon IG; Keating GL; Rye DB Sleep; 2005 Feb; 28(2):169-76. PubMed ID: 16171240 [TBL] [Abstract][Full Text] [Related]
32. Etiologic subtypes of attention-deficit/hyperactivity disorder: brain imaging, molecular genetic and environmental factors and the dopamine hypothesis. Swanson JM; Kinsbourne M; Nigg J; Lanphear B; Stefanatos GA; Volkow N; Taylor E; Casey BJ; Castellanos FX; Wadhwa PD Neuropsychol Rev; 2007 Mar; 17(1):39-59. PubMed ID: 17318414 [TBL] [Abstract][Full Text] [Related]
33. Animal models concerning the role of dopamine in attention-deficit hyperactivity disorder. van der Kooij MA; Glennon JC Neurosci Biobehav Rev; 2007; 31(4):597-618. PubMed ID: 17316796 [TBL] [Abstract][Full Text] [Related]
34. Some speculations concerning a possible biochemical basis of minimal brain dysfunction. Wender PH Ann N Y Acad Sci; 1973 Feb; 205():18-28. PubMed ID: 4570233 [No Abstract] [Full Text] [Related]
36. Methylphenidate-evoked potentiation of extracellular dopamine in the brain of adolescents with premature birth: correlation with attentional deficit. Rosa Neto P; Lou H; Cumming P; Pryds O; Gjedde A Ann N Y Acad Sci; 2002 Jun; 965():434-9. PubMed ID: 12105118 [TBL] [Abstract][Full Text] [Related]
37. Involvement of norepinephrine in the control of activity and attentive processes in animal models of attention deficit hyperactivity disorder. Viggiano D; Ruocco LA; Arcieri S; Sadile AG Neural Plast; 2004; 11(1-2):133-49. PubMed ID: 15303310 [TBL] [Abstract][Full Text] [Related]
38. [Towards an understanding of the molecular mechanisms underlying the pharmacological treatments of attention deficit hyperactivity disorder]. Castellanos FX; Acosta MT Rev Neurol; 2011 Mar; 52 Suppl 1():S155-60. PubMed ID: 21365598 [TBL] [Abstract][Full Text] [Related]